To determine whether the above gene mutations affect the expression of the m6A regulator in patients with clear cell renal cell carcinoma, we also investigated the differences in the expression of m6A regulators between normal and clear cell renal cell carcinoma patients and found that CNV changes may be important for the disruption of m6A regulator factor expression. The gene discussed is METTL3; the disease is clear cell renal carcinoma.